CARES Act Funding in Support of COVID-19 Treatments
Deadline: June 22nd, 2020 by 11:59pm
The Utah Legislature has set aside $2M of CARES Act funding to support efforts focused on partnerships with companies developing treatments for COVID-19 antiviral development, and has charged the University of Utah with evaluating and prioritizing Utah projects for funding. Public and private Utah entities developing therapeutics or diagnostics with potential to improve treatment of COVID-19 are invited to apply.
Funding priority will be given to entities whose work offers the potential to aid directly in the treatment of patients with COVID-19. Development of new therapeutic agents and repurposing of existing agents will be considered, as will all therapeutic modalities, including small molecules, biologics, and nucleic acid-based technologies.
For details on qualifications and application submission please click HERE.